These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35253277)

  • 1. Intertumor and intratumor heterogeneity of PIK3CA mutations in extramammary Paget's disease.
    Kusaba Y; Kajihara I; Myangat TM; Tanaka K; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Sawamura S; Kanemaru H; Nishimura Y; Nakamura-Kashiwada K; Makino K; Miyashita A; Aoi J; Masuguchi S; Fukushima S
    J Dermatol; 2022 May; 49(5):508-514. PubMed ID: 35253277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
    Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
    Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic mutations in extramammary Paget's disease and their clinical relevance.
    Kang Z; Xu F; Zhang QA; Wu Z; Zhang X; Xu J; Luo Y; Guan M
    Int J Cancer; 2013 Feb; 132(4):824-31. PubMed ID: 22821211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.
    Kang Z; Xu F; Zhang QA; Lin J; Wu Z; Zhang X; Luo Y; Xu J; Guan M
    Mod Pathol; 2012 Aug; 25(8):1160-8. PubMed ID: 22522847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic intratumour heterogeneity and clonal evolution in extramammary Paget's disease.
    Tanaka K; Kajihara I; Shimokawa K; Nakamura N; Kusaba Y; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Sawamura S; Kanemaru H; Makino K; Aoi J; Masuguchi S; Suzuki T; Fukushima S
    Eur J Dermatol; 2024 Apr; 34(2):182-192. PubMed ID: 38907549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genetic alterations in extramammary Paget disease using whole exome analysis.
    Kiniwa Y; Yasuda J; Saito S; Saito R; Motoike IN; Danjoh I; Kinoshita K; Fuse N; Yamamoto M; Okuyama R
    J Dermatol Sci; 2019 Apr; 94(1):229-235. PubMed ID: 31023612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155, a potential serum marker of extramammary Paget's disease.
    Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
    BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent
    Takeichi T; Okuno Y; Matsumoto T; Tsunoda N; Suzuki K; Tanahashi K; Kono M; Kikumori T; Muro Y; Akiyama M
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of extramammary Paget's disease (EMPD) in a tertiary hospital in Taiwan.
    Chang YW; Ma H; Liao WC
    World J Surg Oncol; 2021 Apr; 19(1):110. PubMed ID: 33845845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.
    Pierie JP; Choudry U; Muzikansky A; Finkelstein DM; Ott MJ
    J Am Coll Surg; 2003 Jan; 196(1):45-50. PubMed ID: 12517548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased Detection of Driver Mutations in Extramammary Paget Disease.
    Ishida Y; Kakiuchi N; Yoshida K; Inoue Y; Irie H; Kataoka TR; Hirata M; Funakoshi T; Matsushita S; Hata H; Uchi H; Yamamoto Y; Fujisawa Y; Fujimura T; Saiki R; Takeuchi K; Shiraishi Y; Chiba K; Tanaka H; Otsuka A; Miyano S; Kabashima K; Ogawa S
    Clin Cancer Res; 2021 Mar; 27(6):1756-1765. PubMed ID: 33323405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget's Diseases.
    Zhang G; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Mai R
    J Invest Dermatol; 2019 Apr; 139(4):789-795. PubMed ID: 30905357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
    Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
    Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
    Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
    J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease.
    Matsumura Y; Matsumura Y; Nishigori C; Horio T; Miyachi Y
    Int J Cancer; 2004 Aug; 111(2):218-23. PubMed ID: 15197774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget's Disease of the Vulva.
    Stasenko M; Jayakumaran G; Cowan R; Broach V; Chi DS; Rossi A; Hollman TJ; Zehir A; Abu-Rustum NR; Leitao MM
    JCO Precis Oncol; 2020; 4():. PubMed ID: 33015527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.
    Guo H; Qi RQ; Lv YN; Wang HX; Hong YX; Zheng S; Li JH; Gao XH; Chen HD
    Oncotarget; 2016 Apr; 7(17):24559-63. PubMed ID: 27016415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.
    Morris CR; Hurst EA
    Dermatol Surg; 2020 Mar; 46(3):305-311. PubMed ID: 31688232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of circulating tumour DNA in metastatic extramammary Paget's disease.
    Sawamura S; Mijiddorj Myangat T; Kajihara I; Tanaka K; Ide M; Sakamoto R; Otsuka-Maeda S; Kanemaru H; Nishimura Y; Kanazawa-Yamada S; Kashiwada-Nakamura K; Honda N; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Ihn H
    Exp Dermatol; 2022 Mar; 31(3):341-348. PubMed ID: 34676917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extramammary Paget's Disease.
    Asel M; LeBoeuf NR
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):73-85. PubMed ID: 30497678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.